Global Gene Vector Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of Gene Vector
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Gene Vector by Vector Type
  • 1.3.1 Overview: Global Gene Vector Market Size by Vector Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global Gene Vector Consumption Value Market Share by Vector Type in 2022
  • 1.3.3 Lentivirus
  • 1.3.4 Adenovirus
  • 1.3.5 Adeno-associated Virus (AAV)
  • 1.3.6 Plasmid DNA
  • 1.3.7 Others
• 1.4 Global Gene Vector Market by Application
  • 1.4.1 Overview: Global Gene Vector Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Scientific Research
  • 1.4.3 CRO
  • 1.4.4 CDMO
  • 1.4.5 Others (Pharmaceutical, Biotechnology Companies)
• 1.5 Global Gene Vector Market Size & Forecast
• 1.6 Global Gene Vector Market Size and Forecast by Region
  • 1.6.1 Global Gene Vector Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global Gene Vector Market Size by Region, (2018-2029)
  • 1.6.3 North America Gene Vector Market Size and Prospect (2018-2029)
  • 1.6.4 Europe Gene Vector Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific Gene Vector Market Size and Prospect (2018-2029)
  • 1.6.6 South America Gene Vector Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa Gene Vector Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 Lonza
  • 2.1.1 Lonza Details
  • 2.1.2 Lonza Major Business
  • 2.1.3 Lonza Gene Vector Product and Solutions
  • 2.1.4 Lonza Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 Lonza Recent Developments and Future Plans
• 2.2 Merck KGaA
  • 2.2.1 Merck KGaA Details
  • 2.2.2 Merck KGaA Major Business
  • 2.2.3 Merck KGaA Gene Vector Product and Solutions
  • 2.2.4 Merck KGaA Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 Merck KGaA Recent Developments and Future Plans
• 2.3 Oxford Biomedica
  • 2.3.1 Oxford Biomedica Details
  • 2.3.2 Oxford Biomedica Major Business
  • 2.3.3 Oxford Biomedica Gene Vector Product and Solutions
  • 2.3.4 Oxford Biomedica Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 Oxford Biomedica Recent Developments and Future Plans
• 2.4 CGT Catapult
  • 2.4.1 CGT Catapult Details
  • 2.4.2 CGT Catapult Major Business
  • 2.4.3 CGT Catapult Gene Vector Product and Solutions
  • 2.4.4 CGT Catapult Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 CGT Catapult Recent Developments and Future Plans
• 2.5 Charles River Laboratories
  • 2.5.1 Charles River Laboratories Details
  • 2.5.2 Charles River Laboratories Major Business
  • 2.5.3 Charles River Laboratories Gene Vector Product and Solutions
  • 2.5.4 Charles River Laboratories Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 Charles River Laboratories Recent Developments and Future Plans
• 2.6 uniQure N.V.
  • 2.6.1 uniQure N.V. Details
  • 2.6.2 uniQure N.V. Major Business
  • 2.6.3 uniQure N.V. Gene Vector Product and Solutions
  • 2.6.4 uniQure N.V. Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 uniQure N.V. Recent Developments and Future Plans
• 2.7 FUJIFILM Diosynth Biotechnologies
  • 2.7.1 FUJIFILM Diosynth Biotechnologies Details
  • 2.7.2 FUJIFILM Diosynth Biotechnologies Major Business
  • 2.7.3 FUJIFILM Diosynth Biotechnologies Gene Vector Product and Solutions
  • 2.7.4 FUJIFILM Diosynth Biotechnologies Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
• 2.8 Spark Therapeutics, Inc.
  • 2.8.1 Spark Therapeutics, Inc. Details
  • 2.8.2 Spark Therapeutics, Inc. Major Business
  • 2.8.3 Spark Therapeutics, Inc. Gene Vector Product and Solutions
  • 2.8.4 Spark Therapeutics, Inc. Gene Vector Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 Spark Therapeutics, Inc. Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Gene Vector Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of Gene Vector by Company Revenue
  • 3.2.2 Top 3 Gene Vector Players Market Share in 2022
  • 3.2.3 Top 6 Gene Vector Players Market Share in 2022
• 3.3 Gene Vector Market: Overall Company Footprint Analysis
  • 3.3.1 Gene Vector Market: Region Footprint
  • 3.3.2 Gene Vector Market: Company Product Type Footprint
  • 3.3.3 Gene Vector Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Vector Type

• 4.1 Global Gene Vector Consumption Value and Market Share by Vector Type (2018-2023)
• 4.2 Global Gene Vector Market Forecast by Vector Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global Gene Vector Consumption Value Market Share by Application (2018-2023)
• 5.2 Global Gene Vector Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America Gene Vector Consumption Value by Vector Type (2018-2029)
• 6.2 North America Gene Vector Consumption Value by Application (2018-2029)
• 6.3 North America Gene Vector Market Size by Country
  • 6.3.1 North America Gene Vector Consumption Value by Country (2018-2029)
  • 6.3.2 United States Gene Vector Market Size and Forecast (2018-2029)
  • 6.3.3 Canada Gene Vector Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico Gene Vector Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe Gene Vector Consumption Value by Vector Type (2018-2029)
• 7.2 Europe Gene Vector Consumption Value by Application (2018-2029)
• 7.3 Europe Gene Vector Market Size by Country
  • 7.3.1 Europe Gene Vector Consumption Value by Country (2018-2029)
  • 7.3.2 Germany Gene Vector Market Size and Forecast (2018-2029)
  • 7.3.3 France Gene Vector Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom Gene Vector Market Size and Forecast (2018-2029)
  • 7.3.5 Russia Gene Vector Market Size and Forecast (2018-2029)
  • 7.3.6 Italy Gene Vector Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific Gene Vector Consumption Value by Vector Type (2018-2029)
• 8.2 Asia-Pacific Gene Vector Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific Gene Vector Market Size by Region
  • 8.3.1 Asia-Pacific Gene Vector Consumption Value by Region (2018-2029)
  • 8.3.2 China Gene Vector Market Size and Forecast (2018-2029)
  • 8.3.3 Japan Gene Vector Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea Gene Vector Market Size and Forecast (2018-2029)
  • 8.3.5 India Gene Vector Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia Gene Vector Market Size and Forecast (2018-2029)
  • 8.3.7 Australia Gene Vector Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America Gene Vector Consumption Value by Vector Type (2018-2029)
• 9.2 South America Gene Vector Consumption Value by Application (2018-2029)
• 9.3 South America Gene Vector Market Size by Country
  • 9.3.1 South America Gene Vector Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil Gene Vector Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina Gene Vector Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa Gene Vector Consumption Value by Vector Type (2018-2029)
• 10.2 Middle East & Africa Gene Vector Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa Gene Vector Market Size by Country
  • 10.3.1 Middle East & Africa Gene Vector Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey Gene Vector Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia Gene Vector Market Size and Forecast (2018-2029)
  • 10.3.4 UAE Gene Vector Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 Gene Vector Market Drivers
• 11.2 Gene Vector Market Restraints
• 11.3 Gene Vector Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 Gene Vector Industry Chain
• 12.2 Gene Vector Upstream Analysis
• 12.3 Gene Vector Midstream Analysis
• 12.4 Gene Vector Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source